Litcius/Paper detail

Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes

J. S. Westerdahl, Kelsey B. Nusbaum, Catherine Chung, Benjamin H. Kaffenberger, Alex G. Ortega‐Loayza

2021Journal of Dermatological Treatment24 citationsDOI

Abstract

Pyoderma gangrenosum (PG) is a rare neutrophilic skin disease characterized by painful skin ulcerations with violaceous borders, although pustular, bullous, and vegetative clinical-pathological var...

Topics & Concepts

Pyoderma gangrenosumMedicineUstekinumabDermatologyPathologicalNeutrophilic dermatosisPathologyDiseaseInfliximabAutoimmune and Inflammatory DisordersHidradenitis Suppurativa and TreatmentsAutoimmune Bullous Skin Diseases
Ustekinumab as adjuvant treatment for all pyoderma gangrenosum subtypes | Litcius